Sean Ellis
CIK 1904752 · last filed 2026-03-09
Sean Ellis is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider bought $12.3K of ENTX on Mar 9, 2026. Across all open-market trades the lifetime net is +$127.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $231.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$231.4K
2
14
$127.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTX | Director | 188,098 | $1.23 | $231.4K | $58.6K | 8 | 2026-03-09 |
| Entera Bio Ltd. (ENTXW) Delisted | Director | 62,100 | $0.00 | $75 | $68.4K | 6 | 2023-01-04 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | ENTX | Buy (P) | +10,000 | $12.3K | EDGAR |
| 2026-02-11 | ENTX | Buy (P) | +18,000 | $22.3K | EDGAR |
| 2026-01-02 | ENTX | Grant (A) | +25,371 | $0 | EDGAR |
| 2025-01-17 | ENTX | Grant (A) | +7,100 | $0 | EDGAR |
| 2024-10-04 | ENTX | Grant (A) | +7,466 | $0 | EDGAR |
| 2024-08-29 | ENTX | Grant (A) | +18,061 | $0 | EDGAR |
| 2024-01-03 | ENTX | Grant (A) | — | $0 | EDGAR |
| 2023-08-22 | ENTX | Buy (P) | +40,000 | $24.0K | EDGAR |
| 2023-01-04 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-14 | Entera Bio Ltd. (ENTXW) Delisted | Buy (P) | +30,000 | $15.9K | EDGAR |